The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VIR FINANCIAL STATEMENTS

Vir Biotechnology Inc — balance sheet, income statement and cash flow trends

VIRVir Biotechnology Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
01 B2 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue303.2 M $Gross Profit515.5 M $ · 170%Operating Income-269.8 M $ · -89%Pre-tax Income-251.3 M $ · -83%Net Income to Owners-251.7 M $ · -83%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue303.2 M $+1,495.9%
Gross Profit515.5 M $—
Operating Income-269.8 M $—
EBITDA-244.4 M $—
Net Income to Owners-251.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B3 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.2 B
  • Equity982.5 M $81%
  • Current Liabilities95 M $8%
  • Long-term Liabilities137.4 M $11%

Key Figures

YoY change
Total Assets1.2 B $+1.9%
Total Liabilities232.3 M $-5.2%
Total Equity982.5 M $+3.7%
Cash & ST Investments528.6 M $-12.8%
Total Debt93.3 M $-8.8%
Net Debt-185.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
01 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-334.9 M $Operating-46.4 M $Investing404.6 M $Financing23.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-334.9 M $—
Capital Expenditures5.6 M $-37.1%
Free Cash Flow-331.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VIR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.